
Yesterday, Steffen Thirstrup was announced as the new chief medical officer of the European Medicines Agency (EMA), and he is now set to return to the EU’s regulatory work.
The new appointee has previously led the division for medicines assessment and clinical trials at the Danish Health Authority, and has also served in a number of positions at the EMA, including as the Danish member of the agency’s expert committee, the CHMP.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app